Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apoferritin is the iron-free form of ferritin, a globular protein complex composed of 24 polypeptide subunits that self-assemble into a hollow, spherical shell. It serves as the precursor to ferritin, acquiring iron for storage and release as needed for cellular metabolism. Apoferritin itself has a molecular mass of approximately 450–480 kDa and forms a cage-like structure about 12 nm in diameter, with a 7–8 nm internal cavity where iron is stored once it is taken up. In mammals, the composition of the apoferritin shell may vary according to tissue due to a variable ratio of light (L) and heavy (H) chain subunits, which influences its properties. Its chief biological role is to act as a storage buffer for iron, protecting the cell from iron-mediated oxidative stress and helping maintain iron homeostasis. Unlike holoferritin (the iron-loaded form), apoferritin does not contain iron. Although it is not a classical therapeutic "target" like a receptor, enzyme, or transporter, it is of scientific interest in studies of protein aggregation and amyloid diseases, and as a nanomaterial scaffold. Apoferritin is not a therapeutic target in the conventional sense, nor is it typically the direct focus of drug development. However, ferritin (the iron-loaded form) plays key roles in iron metabolism disorders and is measured as a biomarker in blood, but this refers to ferritin overall, not specifically apoferritin. There is nothing wrong with the name "apoferritin," but it is more accurately a protein form rather than a conventional drug target. If structured, apoferritin should be mapped as an iron storage protein, not as the main active site of therapeutic agents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin (apoferritin, iron-free form) (Apoferritin).